Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Understand when to choose target date retirement over index and why the choice matters for long-term planning. This intro explains the core considerations for a simple, informed decision.
25,703 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Aehr Test Systems stock jumped 46% in a single month amid upbeat contract news and rising demand for burn-in testing....
Bitcoin climbs back toward $72,000 after the Fed keeps rates unchanged, as traders weigh geopolitical risks and oil-p...
As crypto markets shift into a new cycle, investors wonder where will chainlink (link) fit. This guide breaks down LI...
Markets pull back as uncertainty weighs on equities; Nvidia remains in focus after upgrades. We track the S&P 500, oi...
A big new stake in Ryan Specialty Holdings hints at growing confidence from a niche investor. This article breaks dow...
CrowdStrike is approaching a stock split, but smart investors look beyond the headline. Here are three solid reasons ...
A Google Gemini AI forecast points to a turbocharged Solana rally by late 2026. The model highlights network architec...
NASA gears up a bold robotic rescue to preserve the aging Swift Observatory, a move that could influence space-tech i...
AI-driven capex is lifting lithography demand, placing ASML at the center of a multiyear upgrade cycle. This piece ex...
As DNOW readies its 2025 earnings narrative, investors should focus on backlog, free cash flow, and guidance. This gu...
Ethereum faces renewed downside risk as momentum wanes. Traders watch $2,150 on the near term and a crucial $2,000 le...